182 related articles for article (PubMed ID: 7853798)
1. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
Díez JJ; Iglesias PL; Sastre J; Gómez-Pan A; Selgas R; Martínez-Ara J; Miguel JL; Méndez J
Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
[TBL] [Abstract][Full Text] [Related]
2. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients.
Tokgöz B; Utaş C; Dogukan A; Güven M; Taşkapan H; Oymak O; Keleştimur F
Perit Dial Int; 2001; 21(5):448-54. PubMed ID: 11757827
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
[TBL] [Abstract][Full Text] [Related]
7. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
Iglesias P; Selgas R; Méndez J; Fernández-Reyes MJ; Bajo MA; Aguilera A; Díez JJ
Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.
Díez JJ; Sastre J; Iglesias P; Selgas R; Romero JR; Méndez J; Gómez-Pan A
Adv Perit Dial; 1992; 8():340-5. PubMed ID: 1361819
[TBL] [Abstract][Full Text] [Related]
9. Increased growth hormone response to growth hormone releasing hormone induced by erythropoietin in uraemic patients.
Cantalamessa L; Cremagnani L; Orsatti A; Vigna L; Buccianti G
Clin Endocrinol (Oxf); 1991 Jan; 34(1):85-9. PubMed ID: 2004477
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patients.
Diez JJ; Iglesias P; Sastre J; Gomez-Pan A; Mendez J; Bajo MA; Selgas R
Adv Perit Dial; 1994; 10():275-81. PubMed ID: 7999845
[TBL] [Abstract][Full Text] [Related]
11. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
[TBL] [Abstract][Full Text] [Related]
13. Histamine-induced paradoxical growth hormone response to thyrotropin-releasing hormone in normal men.
Knigge U; Thuesen B; Wollesen F; Dejgaard A; Christiansen PM
J Clin Endocrinol Metab; 1984 Apr; 58(4):692-7. PubMed ID: 6421867
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
Zanoboni A; Gibillini M; Cucchi MR; Zanoboni Muciaccia W; Zanussi C
J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly.
Giustina A; Doga M; Bresciani E; Bussi AR; Chiesa L; Misitano V; Giustina G
Metabolism; 1995 Mar; 44(3):379-83. PubMed ID: 7885285
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients.
Díez JJ; Iglesias P; Bajo MA; de Alvaro F; Selgas R
Nephron; 1997; 77(2):169-75. PubMed ID: 9346383
[TBL] [Abstract][Full Text] [Related]
17. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
[TBL] [Abstract][Full Text] [Related]
19. Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.
Sartorio A; Spada A; Bochicchio D; Atterrato A; Morabito F; Faglia G
Neuroendocrinology; 1986; 44(4):470-4. PubMed ID: 3102991
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin inhibition of thyrotropin-releasing hormone- and growth hormone-releasing factor-induced growth hormone secretion in young and adult anesthetized chickens.
Scanes CG; Harvey S
Gen Comp Endocrinol; 1989 Aug; 75(2):256-64. PubMed ID: 2572506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
